News
The Diller Scientific Retreat: Building a Culture to Fight the Disease
In concept, it’s simple: Figure out how the cancer works, develop treatments that target the problem areas and cure the disease. In practice, of course, those working in the field know there is nothing simple about this lethal, at times heartbreaking contest of whack-a-mole. Tracking types, sub
Online Smoking Intervention Shows Cost-Effective Way to Distribute Health Resources Worldwide
An online smoking cessation program that offered personalized guidance and support free of charge to smokers worldwide prompted thousands to quit, and should be used as a blueprint for other global health initiatives, according to one of its founders. Ricardo F. Muñoz, PhD, professor emeritus of
Allan Balmain Elected into Royal Society
VIDEO: Interview with Dr. Allan Balmain. Dr. Allan Balmain, an internationally known expert in cancer genetics, has been elected a Fellow of The Royal Society, the oldest continuously operating scientific society in the world. Balmain, the Barbara Bass Bakar Distinguished Professor in Cancer
HDFCCC and Kure It Announce UCSF Grant Recipient for Underfunded Cancer Research
The Helen Diller Family Comprehensive Cancer Center of the University of California, San Francisco and Kure It Cancer Research are pleased to announce that Sabine Mueller, M.D., Ph.D., will receive a 2015 HDFCCC-Kure It Cancer Research Grant for Underfunded Cancer Research. The Helen Diller Family
University of California Medical Campuses Lay Framework for Drug Discovery Alliance
On April 15, 2015, more than forty leaders from across the University of California (UC) system joined representatives from the biomedical industry to discuss plans for strengthening UC’s position as a leader in drug, device and diagnostics development. The meeting was part of the Drug and Device
4 UCSF Faculty Elected to American Academy of Arts and Sciences' 2015 Class
Frank McCormick, Robert Nussbaum and James Wells are Helen Diller Family Comprehensive Cancer Center members. Renowned UC San Francisco pioneers in cancer, biochemistry, medical genetics and pharmaceutical sciences have been elected as members of the American Academy of Arts and Sciences, which
UCSF joins lung cancer dream team
Previous HDFCCC director and long-time RAS researcher Frank McCormick will join a group of prominent cancer research and treatment institutions in a new Stand Up To Cancer (SU2C)-American Cancer Society $20 million Dream Team to combat lung cancer. Stand Up To Cancer (SU2C) and the American Cancer